Related references
Note: Only part of the references are listed.Large uncertainty in individual polygenic risk score estimation impacts PRS-based risk stratification
Yi Ding et al.
NATURE GENETICS (2022)
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening
Sarah Benafif et al.
BJU INTERNATIONAL (2022)
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk
Pooja Middha Kapoor et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps
Adebowale Adeyemo et al.
NATURE MEDICINE (2021)
Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
Mikey B. Lebrett et al.
JOURNAL OF MEDICAL GENETICS (2021)
The cost-effectiveness of prostate cancer screening using the Stockholm3 test
Andreas A. Karlsson et al.
PLOS ONE (2021)
Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts
Rebecca E. Graff et al.
NATURE COMMUNICATIONS (2021)
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
Thomas Callender et al.
JAMA NETWORK OPEN (2021)
Cost effectiveness analysis of a polygenic risk tailored breast cancer screening programme in Singapore
Jerry Zeng Yang Wong et al.
BMC HEALTH SERVICES RESEARCH (2021)
Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation
John Graves et al.
MEDICAL DECISION MAKING (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Clarifying the Trade-Offs of Risk-Stratified Screening for Prostate Cancer: A Cost-Effectiveness Study
Nathaniel Hendrix et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)
The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis
Chloe Thomas et al.
CANCER PREVENTION RESEARCH (2021)
Breast cancer polygenic risk scores: a 12-month prospective study of patient reported outcomes and risk management behavior
Tatiane Yanes et al.
GENETICS IN MEDICINE (2021)
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score
Chi Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Molecular cancer screening: in search of evidence
Sana Raoof et al.
NATURE MEDICINE (2021)
Prostate Cancer Predisposition
Yasin Bhanji et al.
UROLOGIC CLINICS OF NORTH AMERICA (2021)
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models
Edward C. F. Wilson
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2021)
Will polygenic risk scores for cancer ever be clinically useful?
Amit Sud et al.
NPJ PRECISION ONCOLOGY (2021)
Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History
Dayna R. Cenin et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
Christopher McCabe et al.
PHARMACOECONOMICS (2020)
The challenge of early detection in cancer
Nora Pashayan et al.
SCIENCE (2020)
Understanding polygenic models, their development and the potential application of polygenic scores in healthcare
Chantal Babb de Villiers et al.
JOURNAL OF MEDICAL GENETICS (2020)
Polygenic risk scores: from research tools to clinical instruments
Cathryn M. Lewis et al.
GENOME MEDICINE (2020)
Tutorial: a guide to performing polygenic risk score analyses
Shing Wan Choi et al.
NATURE PROTOCOLS (2020)
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Akl C. Fahed et al.
NATURE COMMUNICATIONS (2020)
Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential
Steffie K. Naber et al.
JNCI CANCER SPECTRUM (2020)
What Are Polygenic Scores and Why Are They Important?
Leo P. Sugrue et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Nasim Mavaddat et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Discovery of common and rare genetic risk variants for colorectal cancer
Jeroen R. Huyghe et al.
NATURE GENETICS (2019)
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study
Tom Callender et al.
PLOS MEDICINE (2019)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
The personal and clinical utility of polygenic risk scores
Ali Torkamani et al.
NATURE REVIEWS GENETICS (2018)
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants
Tokhir Dadaev et al.
NATURE COMMUNICATIONS (2018)
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer A Life-Table Model
Nora Pashayan et al.
JAMA ONCOLOGY (2018)
Lynch Syndrome-Associated Colorectal Cancer
Frank A. Sinicrope
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial
Haitao Chen et al.
PROSTATE (2016)
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study
Henrik Gronberg et al.
LANCET ONCOLOGY (2015)
Inherited Predisposition to Cancer: Introduction and Overview
Mark Robson et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Individual and Cumulative Effect of Prostate Cancer Risk-Associated Variants on Clinicopathologic Variables in 5,895 Prostate Cancer Patients
A. Karim Kader et al.
PROSTATE (2009)
Development and validation of a grading system for the quality of cost-effectiveness studies
CF Chiou et al.
MEDICAL CARE (2003)